NEURO-PHARMACOLOGICAL PROFILE OF MD-780515, A NEW REVERSIBLE INHIBITOR OF TYPE-A MONOAMINE-OXIDASE
- 1 January 1982
- journal article
- research article
- Vol. 259 (2) , 194-221
Abstract
In several classical screening procedures, MD 780515 possessed potential antidepressant activity consistent with preferential and short-acting inhibition of type A monoamine oxidase [in mice]. The ED in the tests for antidepressant activity were much lower than the LD and were similar to, or lower than, those for reference drugs. MD 790515 showed some anticholinergic activity.This publication has 18 references indexed in Scilit:
- SIGNIFICANCE OF MONOAMINE OXIDASE INHIBITION FOR THE PHARMACOLOGICAL AND CLINICAL EFFECTS OF HYDRAZINE DERIVATIVESAnnals of the New York Academy of Sciences, 2006
- Behavioural despair in rats: A new model sensitive to antidepressant treatmentsPublished by Elsevier ,2002
- BEHAVIORAL DESPAIR IN MICE - PRIMARY SCREENING-TEST FOR ANTIDEPRESSANTS1977
- Continuous avoidance as a base-line for measuring behavioral effects of drugsPsychopharmacology, 1962
- BEHAVIORAL EFFECTS AND BRAIN AMINE CONTENT IN RATS1961
- ANTICONVULSANT AND ANTITREMOR EFFECTS OF CHLORPHENOXAMINE1961
- Correlation of Tryptamine-Induced Convulsions in Rats with Brain Tryptamine ConcentrationExperimental Biology and Medicine, 1960
- PHARMACOLOGY OF IPRONIAZID AND OTHER AMINE OXIDASE INHIBITORSAnnals of the New York Academy of Sciences, 1959
- COMPARATIVE ASSAYS OF ANTIEPILEPTIC DRUGS IN MICE AND RATS1952
- PROPERTIES OF MAXIMAL SEIZURES, AND THEIR ALTERATION BY ANTICONVULSANT DRUGS AND OTHER AGENTSJournal of Neurophysiology, 1946